1 Bourke A. The biology of the naked mole-rat. Trends Ecol Evol 1991;6:171–2. https://doi.org/10.1016/0169-5347(91)90064-5.
2 Schuhmacher L-N, Husson Z, Smith ESJ. The naked mole-rat as an animal model in biomedical research: current perspectives. Open Access Anim Physiol 2015;7:137–48. https://doi.org/10.2147/OAAP.S50376.
3 Jarvis JUM. Eusociality in a mammal: Cooperative breeding in naked mole-rat colonies. Science (80- ) 1981;212:571–3. https://doi.org/10.1126/science.7209555.
4 Buffenstein R. The naked mole-rat: A new long-living model for human aging research. J Gerontol Ser A Biol Sci Med Sci 2005;60:1369–77. https://doi.org/10.1093/gerona/60.11.1369.
5 Edrey YH, Hanes M, Pinto M, Mele J, Buffenstein R. Successful aging and sustained good health in the naked mole rat: A long-lived mammalian model for biogerontology and biomedical research. ILAR J 2011;52:41–53. https://doi.org/https://doi.org/10.1093/ilar.52.1.41.
6 Fang X, Seim I, Huang Z, Gerashchenko M V., Xiong Z, Turanov AA, et al. Adaptations to a Subterranean Environment and Longevity Revealed by the Analysis of Mole Rat Genomes. Cell Rep 2014. https://doi.org/10.1016/j.celrep.2014.07.030.
7 Daly JTM, Buffenstein R. Skin morphology and its role in thermoregulation in mole-rats, Heterocephalus glaber and Cryptomys hottentotus. J Anat 1998;193:495–502.
8 Lam C Tsoi, Spain SL, Jo Knight, Eva Ellinghaus, Philip E Stuart, Francesca Capon, et al. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat Genet 2012;44:1341–8.
9 Rendon A, Schäkel K. Psoriasis pathogenesis and treatment. Int J Mol Sci 2019;20. https://doi.org/10.3390/ijms20061475.
10 Parisi R, Symmons DPM, Griffiths CEM, Ashcroft DM. Global epidemiology of psoriasis: A systematic review of incidence and prevalence. J Invest Dermatol 2013;133:377–85. https://doi.org/10.1038/jid.2012.339.
11 Enamandram M, Kimball AB. Psoriasis epidemiology: The interplay of genes and the environment. J Invest Dermatol 2013;133:287–9. https://doi.org/10.1038/jid.2012.434.
12 Korman NJ. Management of psoriasis as a systemic disease: what is the evidence? Br J Dermatol 2019:bjd.18245. https://doi.org/10.1111/bjd.18245.
13 Lai CY, Su YW, Lin KI, Hsu LC, Chuang TH. Natural modulators of endosomal Toll-Like receptor-mediated psoriatic skin inflammation. J Immunol Res 2017;2017. https://doi.org/10.1155/2017/7807313.
14 Kim WB, Jerome D, Yeung J. Diagnosis and management of psoriasis. Can Fam Physician 2017;63:278–285.
15 Sundarrajan S, Arumugam M. Comorbidities of psoriasis - Exploring the links by network approach. PLoS One 2016;11. https://doi.org/10.1371/journal.pone.0149175.
16 Lowes MA, Suárez-Fariñas M, Krueger JG. Immunology of Psoriasis. Annu Rev Immunol 2014;32:227–55. https://doi.org/10.1146/annurev-immunol-032713-120225.
17 Ayala-Fontanez N, Soler D, McCormick T. Current knowledge on psoriasis and autoimmune diseases. Psoriasis Targets Ther 2016;6:7–32. https://doi.org/10.2147/ptt.s64950.
18 Zhao J, Di T, Wang Y, Wang Y, Liu X, Liang D, et al. Paeoniflorin inhibits imiquimod-induced psoriasis in mice by regulating Th17 cell response and cytokine secretion. Eur J Pharmacol 2016. https://doi.org/10.1016/j.ejphar.2015.12.040.
19 Arits AHMM, Mosterd K, Essers BA, Spoorenberg E, Sommer A, De Rooij MJM, et al. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial. Lancet Oncol 2013;14:647–54. https://doi.org/10.1016/S1470-2045(13)70143-8.
20 Arits AHMM, Spoorenberg E, Mosterd K, Nelemans P, Kelleners-Smeets NWJ, Essers BAB. Cost-effectiveness of topical imiquimod and fluorouracil vs. photodynamic therapy for treatment of superficial basal-cell carcinoma. Br J Dermatol 2014;171:1501–7. https://doi.org/10.1111/bjd.13066.
21 Paoli J, Gyllencreutz JD, Fougelberg J, Backman EJ, Modin M, Polesie S, et al. Nonsurgical Options for the Treatment of Basal Cell Carcinoma. Dermatol Pract Concept 2019;9:75–81. https://doi.org/10.5826/dpc.0902a01.
22 Edwards L, Ferenczy A, Eron L, Baker D, Owens ML, Fox TL, et al. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus. Arch Dermatol 1998;134:25–30.
23 Hengge UR, Esser S, Schultewolter T, Behrendt C, Meyer T, Stockfleth E, et al. Self-administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum. Br J Dermatol 2000;143:1026–31. https://doi.org/10.1046/j.1365-2133.2000.03777.x.
24 Gollnick H, Dirschka T, Ostendorf R, Kerl H, Kunstfeld R. Long-term clinical outcomes of imiquimod 5% cream versus diclofenac 3% gel for actinic keratosis on the face or scalp: a pooled analysis of two randomized controlled trials. J Eur Acad Dermatology Venereol 2020;34:82–9. https://doi.org/10.1111/jdv.15868.
25 Altalhab S. The effectiveness of imiquimod 5% cream as an anti-wrinkle treatment: A pilot study. J Cosmet Dermatol 2019;18:1729–32. https://doi.org/10.1111/jocd.12939.
26 Hanna E, Abadi R, Abbas O. Imiquimod in dermatology: an overview. Int J Dermatol 2016;55:831–44. https://doi.org/10.1111/ijd.13235.
27 Wu JK, Siller G, Strutton G. Psoriasis induced by topical imiquimod. Australas J Dermatol 2004;45:47–50.
28 Fanti PA, Dika E, Vaccari S, Miscial C, Varotti C. Generalized psoriasis induced by topical treatment of actinic keratosis with imiquimod. Int J Dermatol 2006;45:1464–5. https://doi.org/10.1111/j.1365-4632.2006.02980.x.
29 Varma SR, Sivaprakasam TO, Mishra A, Prabhu S, Rafiq M, Rangesh P. Imiquimod-induced psoriasis-like inflammation in differentiated Human keratinocytes: Its evaluation using curcumin. Eur J Pharmacol 2017;813:33–41. https://doi.org/10.1016/j.ejphar.2017.07.040.
30 Flutter B, Nestle FO. TLRs to cytokines: Mechanistic insights from the imiquimod mouse model of psoriasis. Eur J Immunol 2013;43:3138–46. https://doi.org/10.1002/eji.201343801.
31 van der Fits L, Mourits S, Voerman JSA, Kant M, Boon L, Laman JD, et al. Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis. J Immunol 2009;182:5836–45. https://doi.org/10.4049/jimmunol.0802999.
32 Luo DQ, Wu HH, Zhao YK, Liu JH, Wang F. Different imiquimod creams resulting in differential effects for imiquimod-induced psoriatic mouse models. Exp Biol Med 2016;241:1733–8. https://doi.org/10.1177/1535370216647183.
33 Dou R, Liu Z, Yuan X, Xiangfei D, Bai R, Bi Z, et al. PAMs ameliorates the imiquimod-induced psoriasis-like skin disease in mice by inhibition of translocation of NF-κB and production of inflammatory cytokines. PLoS One 2017;12:e0176823. https://doi.org/10.1371/journal.pone.0176823.
34 Wohn CT, Pantelyushin S, Ober-Blöbaum JL, Clausen BE. Aldara-induced psoriasis-like skin inflammation: isolation and characterization of cutaneous dendritic cells and innate lymphocytes. Methods Mol Biol 2014;1193:171–85. https://doi.org/10.1007/978-1-4939-1212-4_16.
35 Ilacqua AN, Kirby AM, Pamenter ME. Behavioural responses of naked mole rats to acute hypoxia and anoxia. Biol Lett 2017;13. https://doi.org/10.1098/rsbl.2017.0545.
36 Park TJ, Lu Y, Jüttner R, Smith ESJ, Hu J, Brand A, et al. Selective inflammatory pain insensitivity in the African naked mole-rat (Heterocephalus glaber). PLoS Biol 2008;6:e13. https://doi.org/10.1371/journal.pbio.0060013.
37 Smith SJE, Blass GR, Lewin GR, Park TJ. Absence of Histamine-Induced Itch in the African Naked Mole-Rat and “Rescue” by Substance P. Mol Pain 2010;6:29. https://doi.org/10.1186/1744-8069-6-29.
38 Liang S, Mele J, Wu Y, Buffenstein R, Hornsby PJ. Resistance to experimental tumorigenesis in cells of a long-lived mammal, the naked mole-rat (Heterocephalus glaber). Aging Cell 2010;9:626–35. https://doi.org/10.1111/j.1474-9726.2010.00588.x.
39 Seluanov A, Hine C, Azpurua J, Feigenson M, Bozzella M, Mao Z, et al. Hypersensitivity to contact inhibition provides a clue to cancer resistance of naked mole-rat. Poc Nat’l Acad Sci 2009;106:19352–19357.
40 Tian X, Azpurua J, Hine C, Vaidya A, Myakishev-Rempel M, Ablaeva J, et al. High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat. Nature 2013;499:346–9. https://doi.org/10.1038/nature12234.
41 Petruseva IO, Evdokimov AN, Lavrik OI. Genome Stability Maintenance in Naked Mole-Rat. Acta Naturae 2017;9:31–41.
42 Mead R. The design of experiments : statistical principles for practical applications. Cambridge University Press; 1988.
43 El Malki K, Karbach SH, Huppert J, Zayoud M, Reißig S, Schüler R, et al. An alternative pathway of imiquimod-induced psoriasis-like skin inflammation in the absence of interleukin-17 receptor a signaling. J Invest Dermatol 2013. https://doi.org/10.1038/jid.2012.318.
44 Li ZJ, Sohn KC, Choi DK, Shi G, Hong D, Lee HE, et al. Roles of TLR7 in Activation of NF-κB Signaling of Keratinocytes by Imiquimod. PLoS One 2013;8:e77159. https://doi.org/10.1371/journal.pone.0077159.
45 Walter A, Schäfer M, Cecconi V, Matter C, Urosevic-Maiwald M, Belloni B, et al. Aldara activates TLR7-independent immune defence. Nat Commun 2013;4:1560. https://doi.org/10.1038/ncomms2566.
46 Hilton HG, Rubinstein ND, Janki P, Ireland AT, Bernstein N, Fong NL, et al. Single-cell transcriptomics of the naked mole-rat reveals unexpected features of mammalian immunity. PLOS Biol 2019;17:e3000528. https://doi.org/10.1371/journal.pbio.3000528.
47 Garzorz-Stark N, Lauffer F, Krause L, Thomas J, Atenhan A, Franz R, et al. Toll-like receptor 7/8 agonists stimulate plasmacytoid dendritic cells to initiate TH17-deviated acute contact dermatitis in human subjects. J Allergy Clin Immunol 2018;141:1320-1333.e11. https://doi.org/10.1016/j.jaci.2017.07.045.
48 Deckers J, Hammad H, Hoste E. Langerhans cells: Sensing the environment in health and disease. Front Immunol 2018;9:93. https://doi.org/10.3389/fimmu.2018.00093.
49 Greten FR, Grivennikov SI. Inflammation and Cancer: Triggers, Mechanisms, and Consequences. Immunity 2019;51:27–41. https://doi.org/10.1016/j.immuni.2019.06.025.
50 Lu H, Ouyang W, Huang C. Inflammation, a key event in cancer development. Mol Cancer Res 2006;4:221–33. https://doi.org/10.1158/1541-7786.MCR-05-0261.
51 Sui X, Lei L, Chen L, Xie T, Li X. Inflammatory microenvironment in the initiation and progression of bladder cancer. Oncotarget 2017;8:93279–94. https://doi.org/10.18632/oncotarget.21565.
52 Hamza M, Tohid H, Maibach H. Shaving effects on percutaneous penetration: clinical implications. Cutan Ocul Toxicol 2015;34:335–43. https://doi.org/10.3109/15569527.2014.966109.
53 Pany A, Klang V, Brunner M, Ruthofer J, Schwarz E, Valenta C. Effect of Physical and Chemical Hair Removal Methods on Skin Barrier Function in vitro: Consequences for a Hydrophilic Model Permeant. Skin Pharmacol Physiol 2019;32:8–21. https://doi.org/10.1159/000493168.
54 Kim H-R, Lee A, Choi E-J, Hong M-P, Kie J-H, Lim W, et al. Reactive oxygen species prevent imiquimod-induced psoriatic dermatitis through enhancing regulatory T cell function. PLoS One 2014;9:e91146. https://doi.org/10.1371/journal.pone.0091146.
55 Andziak B, O’Connor TP, Qi W, Dewaal EM, Pierce A, Chaudhuri AR, et al. High oxidative damage levels in the longest-living rodent, the naked mole-rat. Aging Cell 2006;5:463–71. https://doi.org/10.1111/j.1474-9726.2006.00237.x.
56 Saldmann F, Viltard M, Leroy C, Friedlander G. The Naked Mole Rat: A Unique Example of Positive Oxidative Stress 2019. https://doi.org/10.1155/2019/4502819.
57 Andziak B, Buffenstein R. Disparate patterns of age-related changes in lipid peroxidation in long-lived naked mole-rats and shorter-lived mice. Aging Cell 2006;5:525–32. https://doi.org/10.1111/j.1474-9726.2006.00246.x.